In summary, GLP-1 contributes to myocardial contractility through enhanced calcium handling, metabolic modulation, and improved coronary blood flow, making it a valuable therapeutic target in cardiac dysfunction, especially heart failure [27,28]. The gene discussed is GCG; the disease is heart failure.